The Advisory Committee on Immunization Practices (ACIP) recently voted on its annual influenza vaccination recommendations for 2015-16, but stopped short of recommending the nasal spray flu vaccine for children ages 2 to 8.
Made up of a panel of health experts, the ACIP advises the U.S. Centers for Disease Control and Prevention (CDC). The committee makes it recommendations based on data gathered from the most recent studies.
Although the ACIP reconfirmed that everyone ages 6 months old and older should receive the yearly influenza vaccine, recent studies have shown the nasal version of the flu vaccine does not provide better protection against influenza. The ACIP originally said the nasal spray vaccine would adequately replace the flu shot in children between the ages of 2 and 8 years old, but rescinded that recommendation after receiving interim data from the U.S. Flu Vaccine Effectiveness Network.
The director of the CDC must accept the recommendations of the ACIP and implement them in the influenza prevention control standards for 2015-2016. These guidelines will be printed in a Morbidity and Mortality Weekly Report, which places these recommendations at the same authority level as official policies of the CDC.